RH and 95% CI for all-cause and CVD mortality for 1 SD increment in plasma glucose for 3,092 adults aged 30–74 years in NHANES II
| . | All-cause mortality . | CVD Mortality . | ||
|---|---|---|---|---|
| Fasting glucose . | 2-h glucose . | Fasting glucose . | 2-h glucose . | |
| Model 1 | ||||
| RH* | 1.10 | 1.14 | 1.09 | 1.13 |
| 95% CI | 1.00–1.22 | 1.00–1.29 | 0.95–1.25 | 0.93–1.38 |
| P value β | 0.02 | 0.03 | 0.56 | 0.61 |
| Model 2 | ||||
| RH* | 1.05 | 1.10 | 1.02 | 1.07 |
| 95% CI | 0.89–1.23 | 0.91–1.33 | 0.79–1.32 | 0.78–1.46 |
| P value β | 0.37 | 0.59 | 0.85 | 0.67 |
| . | All-cause mortality . | CVD Mortality . | ||
|---|---|---|---|---|
| Fasting glucose . | 2-h glucose . | Fasting glucose . | 2-h glucose . | |
| Model 1 | ||||
| RH* | 1.10 | 1.14 | 1.09 | 1.13 |
| 95% CI | 1.00–1.22 | 1.00–1.29 | 0.95–1.25 | 0.93–1.38 |
| P value β | 0.02 | 0.03 | 0.56 | 0.61 |
| Model 2 | ||||
| RH* | 1.05 | 1.10 | 1.02 | 1.07 |
| 95% CI | 0.89–1.23 | 0.91–1.33 | 0.79–1.32 | 0.78–1.46 |
| P value β | 0.37 | 0.59 | 0.85 | 0.67 |
Model 1, proportional hazards model adjusts for either fasting or 2-h glucose; model 2, proportional hazards model adjusts for fasting and 2-h glucose simultaneously. SD for fasting glucose 1.18 mmol/l and for 2-h glucose 3.18 mmol/l.
Adjusted for age (continuous), sex, race (white, nonwhite), education (<high school, ≥high school), smoking (ever, never), physical activity (low, high), BMI (<25, 25≤ to <27, 27≤ to <30, ≥30 kg/m2), systolic blood pressure, total cholesterol–to–HDL cholesterol ratio (continuous).